| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Onyia Jude is a Chief Scientific Officer at Neurocrine Biosciences, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $4.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | NBIX Neurocrine Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 11,000 | $160.25 | $1,762,710.40 | -29.9% | - | - | |
| May 27, 2026 | NBIX Neurocrine Biosciences, Inc. | Chief Scientific Officer | Sale+OE | 11,000 | $155.53 | $1,710,865.20 | -29.9% | - | - | |
| Jul 9, 2025 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sale+OE | 59,819 | $130.46 | $7,803,687.65 | -76.6% | +2.6% | - | |
| Jul 2, 2025 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sale+OE | 20,362 | $130.13 | $2,649,737.60 | -52.7% | +8.5% | - | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sale+OE | 2,879 | $116.79 | $336,238.63 | -7.6% | +1.6% | +6.2% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sale+OE | 126 | $152.97 | $19,273.98 | -0.8% | -29.8% | -10.4% | |
| Nov 29, 2024 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sale+OE | 2,331 | $126.29 | $294,372.67 | -13.1% | -7.3% | +20.0% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sell | 1,432 | $132.94 | $190,371.08 | -9.8% | +1.7% | -12.4% | |
| Jan 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sell | 126 | $141.94 | $17,884.44 | -1.1% | -1.6% | +9.7% | |
| Nov 29, 2023 | NBIX Neurocrine Biosciences Inc | Chief Scientific Officer | Sell | 2,331 | $113.57 | $264,732.84 | -16.6% | +19.8% | +11.6% |